Keurig Dr Pepper (NASDAQ:KDP) Stock Rating Lowered by Hsbc Global Res

Key Points

• Keurig Dr Pepper stock has been downgraded by HSBC Global Research from a "strong-buy" to a "hold" rating, with a price target set at $30.00, down from $42.00.
• The company reported a 6.9% decline in stock value following the downgrade, opening at $28.95 and experiencing a low of $28.93 in the past twelve months.
• Despite the downgrade, Keurig Dr Pepper maintains a consensus rating of "Moderate Buy" from analysts, with an average price target of $38.77.

Keurig Dr Pepper (NASDAQ:KDP - Get Free Report) was downgraded by equities research analysts at Hsbc Global Res from a "strong-buy" rating to a "hold" rating in a research note issued to investors on Tuesday,Zacks.com reports.

Other research analysts also recently issued research reports about the company. Barclays lifted their price objective on Keurig Dr Pepper from $37.00 to $39.00 and gave the stock an "overweight" rating in a report on Monday, July 28th. JPMorgan Chase & Co. reduced their price target on Keurig Dr Pepper from $39.00 to $38.00 and set an "overweight" rating on the stock in a report on Thursday, July 17th. HSBC restated a "hold" rating and set a $30.00 price target (down previously from $42.00) on shares of Keurig Dr Pepper in a report on Tuesday. UBS Group reduced their price target on Keurig Dr Pepper from $42.00 to $40.00 and set a "buy" rating on the stock in a report on Thursday, July 17th. Finally, Deutsche Bank Aktiengesellschaft reduced their price target on Keurig Dr Pepper from $40.00 to $38.00 and set a "buy" rating on the stock in a report on Tuesday. Eleven equities research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $38.77.

Keurig Dr Pepper Stock Down 6.9%

KDP opened at $28.95 on Tuesday. The company has a market cap of $39.33 billion, a P/E ratio of 25.85, a P/E/G ratio of 2.22 and a beta of 0.45. The business's 50-day moving average price is $33.59 and its 200-day moving average price is $33.64. The company has a current ratio of 0.64, a quick ratio of 0.40 and a debt-to-equity ratio of 0.56. Keurig Dr Pepper has a 12 month low of $28.93 and a 12 month high of $38.28.

Keurig Dr Pepper (NASDAQ:KDP - Get Free Report) last released its quarterly earnings data on Thursday, July 24th. The company reported $0.49 EPS for the quarter, hitting the consensus estimate of $0.49. The firm had revenue of $4.16 billion for the quarter, compared to the consensus estimate of $4.14 billion. Keurig Dr Pepper had a return on equity of 11.05% and a net margin of 9.75%.The company's quarterly revenue was up 6.1% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.45 earnings per share. On average, equities analysts expect that Keurig Dr Pepper will post 1.92 EPS for the current year.

Insiders Place Their Bets

In other Keurig Dr Pepper news, insider Mary Beth Denooyer sold 12,000 shares of the company's stock in a transaction that occurred on Thursday, July 17th. The stock was sold at an average price of $33.66, for a total transaction of $403,920.00. Following the transaction, the insider owned 82,511 shares in the company, valued at approximately $2,777,320.26. This represents a 12.70% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Robert James Gamgort sold 208,000 shares of the company's stock in a transaction that occurred on Friday, August 1st. The stock was sold at an average price of $32.90, for a total value of $6,843,200.00. Following the transaction, the director owned 2,292,169 shares in the company, valued at $75,412,360.10. This trade represents a 8.32% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 679,601 shares of company stock worth $22,508,712. Company insiders own 1.00% of the company's stock.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently made changes to their positions in the company. China Universal Asset Management Co. Ltd. grew its holdings in shares of Keurig Dr Pepper by 51.8% during the 1st quarter. China Universal Asset Management Co. Ltd. now owns 33,510 shares of the company's stock worth $1,154,000 after acquiring an additional 11,435 shares during the period. Praxis Investment Management Inc. boosted its position in shares of Keurig Dr Pepper by 112.2% in the 1st quarter. Praxis Investment Management Inc. now owns 19,630 shares of the company's stock worth $672,000 after purchasing an additional 10,380 shares in the last quarter. Aspire Private Capital LLC bought a new stake in shares of Keurig Dr Pepper in the 1st quarter worth approximately $1,177,000. Envestnet Asset Management Inc. boosted its position in shares of Keurig Dr Pepper by 13.7% in the 1st quarter. Envestnet Asset Management Inc. now owns 2,823,185 shares of the company's stock worth $96,609,000 after purchasing an additional 339,530 shares in the last quarter. Finally, Oppenheimer Asset Management Inc. boosted its position in shares of Keurig Dr Pepper by 656.1% in the 1st quarter. Oppenheimer Asset Management Inc. now owns 205,556 shares of the company's stock worth $7,034,000 after purchasing an additional 178,368 shares in the last quarter. Hedge funds and other institutional investors own 93.99% of the company's stock.

Keurig Dr Pepper Company Profile

Keurig Dr Pepper Inc owns, manufactures, and distributors beverages and single serve brewing systems in the United States and internationally. It operates through three segments: U.S. Refreshment Beverages, U.S. Coffee, and International. The U.S. Refreshment Beverages segment manufactures and distributes branded concentrates, syrup, and finished beverages.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.